Skip to main content
HUAPONT LIFE SCIENCES CO., LTD. logo

HUAPONT LIFE SCIENCES CO., LTD. — Investor Relations & Filings

Ticker · 002004 ISIN · CNE000001JJ6 LEI · 3003009TGXJC0JJVTJ07 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,461 across all filing types
Latest filing 2019-08-22 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002004

About HUAPONT LIFE SCIENCES CO., LTD.

https://www.huapont.com.cn

HUAPONT LIFE SCIENCES CO., LTD. operates as a diversified entity specializing in the research, development, manufacturing, and distribution of pharmaceutical and chemical solutions. The company holds a prominent position in the dermatology sector, providing a comprehensive range of therapeutic products for various skin disorders. Its pharmaceutical operations extend to the production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Beyond human health, the organization maintains a significant footprint in the agrochemical sector, focusing on the development and supply of crop protection products, including herbicides and pesticides. The company also integrates healthcare services into its business model, overseeing the operation of medical facilities and specialized clinics. Its strategic focus centers on technological advancement and the maintenance of a robust supply chain to support its global commercial activities.

Recent filings

Filing Released Lang Actions
关于子公司产品新纳入国家医保目录的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Huabang Life Health Co., Ltd. regarding the inclusion of certain subsidiary products into the National Medical Insurance Directory. It details product names, classifications, and the impact of these changes on the company. The document is relatively short (2710 characters) and serves as a formal notification to investors about regulatory changes affecting product listings and potential business impact. It does not contain financial statements, detailed financial analysis, or comprehensive report data. It is not a full annual or interim report, nor is it a call transcript or management discussion. The content fits best as a Regulatory Filing (RNS) because it is a regulatory announcement about product listing changes and their business implications without constituting a full financial or management report.
2019-08-22 Chinese
第七届监事会第七次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a meeting resolution announcement from the Supervisory Board (监事会) of 华邦生命健康股份有限公司 regarding the approval of the 2019 semi-annual report and related audit opinions. It references the 2019 semi-annual report and a special report on the use of raised funds, but does not contain the actual financial statements or detailed report content itself. The document is short (1084 characters) and primarily announces the passing of resolutions and points to where the full reports can be found. This fits the profile of a Regulatory Filing (RNS) rather than the actual Interim/Quarterly Report (IR) or Audit Report (AR).
2019-08-21 Chinese
第七届董事会第十次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 10th meeting of the 7th Board of Directors of Huabang Life Health Co., Ltd. It details the meeting's agenda, voting results, and references to other reports and documents published elsewhere. The document does not contain the full financial report or detailed financial data itself but rather announces the approval of the 2019 semi-annual report and other governance-related documents. It also mentions that some proposals will be submitted to the shareholders' meeting for further approval. The document length is short (1925 characters) and primarily serves as a meeting resolution announcement. Therefore, it fits best into the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors.
2019-08-21 Chinese
独立董事对公司关联方资金占用和对外担保情况的专项说明及独立意见
Audit Report / Information Classification · 95% confidence The document is a special statement and independent opinion by independent directors regarding related party fund occupation and external guarantees of the company for the half-year period ending June 30, 2019. It references regulatory notices from the China Securities Regulatory Commission and Shenzhen Stock Exchange rules, and discusses compliance and risk control related to guarantees and fund occupation. The document is not a full financial report but a specific audit or compliance opinion on certain financial matters. It is not an annual or interim report, nor a general regulatory filing or announcement. It fits best as an Audit Report / Information (AR) because it provides an independent audit opinion on specific financial compliance issues related to related party transactions and guarantees. H1 2019
2019-08-21 Chinese
关于2019年半年度募集资金存放与使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is titled as a "专项报告" (special report) on the storage and use of raised funds (募集资金存放与使用情况的专项报告) for the half-year period of 2019. It details the amounts raised through specific share issuances in 2014 and 2015, the use of those funds, changes in investment projects, and compliance with regulatory requirements. The document references regulatory guidelines from the Shenzhen Stock Exchange and the China Securities Regulatory Commission regarding the management and use of raised funds. It includes detailed tables of fund usage, changes in projects, and bank account balances for the raised funds. The document is not an annual or interim financial report, nor is it an earnings release or a proxy statement. It is a specialized report focused on the management and use of capital raised through share issuances, which fits the category of Capital/Financing Update (CAP). The document length is over 11,000 characters and contains substantive financial data related to fundraising and fund usage, not merely an announcement or certification. Therefore, the appropriate classification is CAP with high confidence.
2019-08-21 Chinese
关于2019年度第二期超短期融资券发行情况的公告
Capital/Financing Update Classification · 100% confidence The document is an announcement regarding the issuance of a short-term financing bond by the company 华邦生命健康股份有限公司 in 2019. It details the registration, approval, issuance amount, interest rate, and dates related to the bond issuance. There is no indication that this is a full financial report, audit, or earnings release. The content focuses on capital raising activity through bond issuance, which fits the category of Capital/Financing Update. The document length is short and it is not a report publication announcement or certification. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2019-08-21 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.